title: Update on contraception: benefits and risks of the new formulations.
abstract: Several new contraceptives have become available to women in recent years. These new agents include ultra-low-dose oral contraceptives as well as injectable, vaginal, and patch formulations. We review these, with emphasis on the Yasmin pill (which contains a new progestin), the Lunelle once-a-month injection, the Ortho Evra patch, the NuvaRing vaginal ring, the Mirena intrauterine device, and emergency contraceptive kits. Patient education regarding these options is essential for patient compliance and satisfaction.
authors.affiliation: Gault Women's Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA. baturp@ccf.org
authors.forename: Pelin
authors.initials: P
authors.lastname: Batur
authors.forename: Julie
authors.initials: J
authors.lastname: Elder
authors.forename: Mark
authors.initials: M
authors.lastname: Mayer
mesh_terms: D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects; D003274:Contraceptive Devices, Female / Q000009:adverse effects / Q000639:trends; D005260:Female; D006801:Humans
chemical_list: D003271:Contraceptive Agents, Female